Inclusion Criteria:  Age ≥ 75 years Histologically confirmed diagnosis of local disease only (cT1-T2 N0 M0) Luminal like A or B (estrogen receptor positive and/or progesterone receptor positive and Her2 negative Tumors) SBRT within 2 months after hormonal therapy start  Exclusion Criteria:  Metastatic Disease Evidence of loco-regional nodal disease Multifocal or multicentric tumors Prior radiotherapy to the region of the study cancer that would result in overlap of therapy fields Concurrent systemic disorders that contraindicate radiotherapy